| Cardiovascular and noncardiovascular mortality among patients starting dialysis DJ de Jager, DC Grootendorst, KJ Jager, PC van Dijk, LMJ Tomas, ... Jama 302 (16), 1782-1789, 2009 | 887 | 2009 |
| Long-term risks for kidney donors G Mjøen, S Hallan, A Hartmann, A Foss, K Midtvedt, O Øyen, A Reisæter, ... Kidney international 86 (1), 162-167, 2014 | 809 | 2014 |
| On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation CB Terwee, FW Dekker, WM Wiersinga, MF Prummel, PMM Bossuyt Quality of life research 12, 349-362, 2003 | 766 | 2003 |
| Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size WM Michels, DC Grootendorst, M Verduijn, EG Elliott, FW Dekker, ... Clinical Journal of the American Society of Nephrology 5 (6), 1003-1009, 2010 | 759 | 2010 |
| Risk of depression in patients with chronic obstructive pulmonary disease and its determinants JG Van Manen, PJE Bindels, FW Dekker, CJ IJzermans, JS Van der Zee, ... Thorax 57 (5), 412-416, 2002 | 676 | 2002 |
| When do we need competing risks methods for survival analysis in nephrology? M Noordzij, K Leffondré, KJ van Stralen, C Zoccali, FW Dekker, KJ Jager Nephrology Dialysis Transplantation 28 (11), 2670-2677, 2013 | 668 | 2013 |
| Predictors of the rate of decline of residual renal function in incident dialysis patients MAM Jansen, AAM Hart, JC Korevaar, FW Dekker, EW Boeschoten, ... Kidney international 62 (3), 1046-1053, 2002 | 638 | 2002 |
| Sample size calculations: basic principles and common pitfalls M Noordzij, G Tripepi, FW Dekker, C Zoccali, MW Tanck, KJ Jager Nephrology dialysis transplantation 25 (5), 1388-1393, 2010 | 562 | 2010 |
| Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey SI Hallan, K Dahl, CM Oien, DC Grootendorst, A Aasberg, J Holmen, ... Bmj 333 (7577), 1047, 2006 | 549 | 2006 |
| Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment MP Merkus, KJ Jager, FW Dekker, EW Boeschoten, P Stevens, RT Krediet, ... American journal of kidney diseases 29 (4), 584-592, 1997 | 538 | 1997 |
| Confounding: what it is and how to deal with it KJ Jager, C Zoccali, A Macleod, FW Dekker Kidney international 73 (3), 256-260, 2008 | 519 | 2008 |
| Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial JC Korevaar, GW Feith, FW Dekker, JG Van Manen, EW Boeschoten, ... Kidney international 64 (6), 2222-2228, 2003 | 488 | 2003 |
| Selection bias and information bias in clinical research G Tripepi, KJ Jager, FW Dekker, C Zoccali Nephron Clinical Practice 115 (2), c94-c99, 2010 | 467 | 2010 |
| Cohort studies: prospective versus retrospective AM Euser, C Zoccali, KJ Jager, FW Dekker Nephron Clinical Practice 113 (3), c214-c217, 2009 | 465 | 2009 |
| High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients N Voormolen, M Noordzij, DC Grootendorst, I Beetz, YW Sijpkens, ... Nephrology Dialysis Transplantation 22 (10), 2909-2916, 2007 | 431 | 2007 |
| Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on … F Termorshuizen, FW Dekker, JG van Manen, JC Korevaar, ... Journal of the American Society of Nephrology 15 (4), 1061-1070, 2004 | 425 | 2004 |
| The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study … F Termorshuizen, JC Korevaar, FW Dekker, JG van Manen, ... American journal of kidney diseases 41 (6), 1293-1302, 2003 | 418 | 2003 |
| Renal replacement therapy in Europe: the results of a collaborative effort by the ERA–EDTA registry and six national or regional registries PCW van Dijk, KJ Jager, F de Charro, F Collart, R Cornet, FW Dekker, ... Nephrology Dialysis Transplantation 16 (6), 1120-1129, 2001 | 409 | 2001 |
| External validation of prognostic models: what, why, how, when and where? CL Ramspek, KJ Jager, FW Dekker, C Zoccali, M van Diepen Clinical Kidney Journal 14 (1), 49-58, 2021 | 393 | 2021 |
| The systemic nature of CKD C Zoccali, R Vanholder, ZA Massy, A Ortiz, P Sarafidis, FW Dekker, ... Nature Reviews Nephrology 13 (6), 344-358, 2017 | 388 | 2017 |
carmine zoccaliRenal Research Institute, New York; Inst. Biol.& Mol.Genetics (BIOGEM), Ariano Irpino and IPNETDirección de correo verificada de biogem.it
